Inclusion Criteria:  Adult subjects (≥ 18 years old) with sleep complaints:  with a frequency of 1 or 2 times per week, OR with a frequency ≥ 3 times per week and duration < 3 months,  Sleep complaints are defined as:  Difficulty initiating sleep, or Difficulty maintaining sleep, or Early-morning awakening with inability to return to sleep. and Causing distress or impairment in social, occupational, educational, academic, behavioral, or other important areas of functioning. Insomnia Severity Index (ISI) score comprised between 11 and 21 (slight to moderate sleep complaints) BMI inferior to 30 (included) Connected to internet and having a smartphone Affiliated person or beneficiary of a social security scheme Free, informed and written consent signed  Exclusion Criteria:  Severe sleep complaints (ISI > 21) OR insomnia with clinical significance consequences as defined by DSM 5 Subject with other organic sleep disorders diagnosed (i.e. sleep apnea, Restless Legs Syndrome) Subject at high risk of suspicion of Obstructive Sleep Apnea Syndrome (OSAS) on the STOP-BANG questionnaire (Snoring, Tiredness, Observed apnea, blood Pressure, Body mass index, Age, Neck circumference and Gender), or a suspicion of Restless Legs Syndrome (RLS) on the RLS screening questionnaire, Subject with a significant medical history in the previous year or still in progress (example: Cancer), Subject with acute psychiatric disorder (mood disorders, severe anxiety disorders, psychosis, addiction interfering with nocturnal sleep). Subject with a history of mood or anxiety disorder currently stabilized could be included. Having initiated a psychotropic treatment for anxiety or mood disorders in the last 2 months or whose treatment dose has been modified for less than 2 months (antidepressant, anxiolytic and antihistamine treatments will be allowed if they are prescribed for a stabilized mood and/or anxiety disorder) Having organic disorders inducing sleep complaints (i.e. Covid < 6 months) Currently treated for insomnia disorders with a pharmaceutical treatment (hypnotic treatments, anxiolytic, antidepressants). Taking food supplements aimed at improving sleep quality in the previous month, Taking food supplements in the previous month containing valerian root extract or lavender oil Taking any pharmaceutical treatment suspected to induce sleep complaints Shift workers and social jet lag Having undertaken trans-meridian travel (± 3H) in the previous month and/or refusing not to undertake trans-meridian travel (± 3H) ) Known drug abuse Alcohol consumption more than 10 standard drinks per week Caffeine consumption more than 5 standard cups/drinks per day Participation in a clinical trial in the previous 3 months that may interfere with the evaluation of the primary endpoint (sleep complaints) or exclusion period still on going Eating disorders: anorexia and bulimia or unstable dietary pattern; Any food allergy documented or suspected to one of the components of the study products; Pregnancy or breast-feeding woman (contraceptive mandatory) Subject under legal protection (guardianship, wardship) or deprived from his rights following administrative or judicial decision;